

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Ritlecitinib iyimithi entsha esiza abantu abanezimo ezithile ze-autoimmune lapho amasosha omzimba ehlasela ngamaphutha izingxenye zomzimba ezinempilo. Isebenza ngokuvimba izindlela ezithile ezibangela ukuvuvukala nokusebenza ngokweqile kwamasosha omzimba.
Le mithi ingeyeqembu elibizwa ngokuthi ama-JAK inhibitors, aklanyelwe ukuthulisa impendulo yamasosha omzimba esebenza ngokweqile. Uma ubhekene nezimo ezinjenge-alopecia areata noma i-vitiligo, udokotela wakho angase acabange ukuthi le ndlela yokwelapha iyindlela yokunakekelwa kwakho.
I-Ritlecitinib iyimithi yomlomo evimba ama-enzyme athile emasosheni akho omzimba abizwa ngokuthi ama-JAK3 kanye nama-TEC kinases. Lawa ma-enzyme ngokuvamile asiza ukuxhumanisa izimpendulo zokuzivikela komzimba, kodwa lapho esebenza ngokweqile, angabangela ukuthi umzimba wakho uhlasele izicubu zawo ezinempilo.
Cabanga ngayo njengebhegi elithambile lemasosha akho omzimba kunokuthi liwavalise ngokuphelele. Imithi isiza ukubuyisela ibhalansi ngokunciphisa izimpawu zokuvuvukala eziholela ekulahlekelweni izinwele ku-alopecia areata kanye nezinguquko zombala wesikhumba ku-vitiligo.
Imisha emakethe, njengoba ithole imvume evela e-FDA eminyakeni yamuva. Lokhu kusho ukuthi odokotela basafunda ngemiphumela yayo yesikhathi eside, kodwa izifundo zakuqala zibonisa imiphumela ethembisayo kubantu abangazange basabele kahle kwezinye izindlela zokwelapha.
I-Ritlecitinib isetshenziselwa ikakhulukazi ukwelapha i-alopecia areata, isimo lapho amasosha akho omzimba ehlasela ama-follicles ezinwele futhi abangele ukulahlekelwa izinwele okungahleliwe. Ingasiza ukukhulisa izinwele kubantu abalahlekelwe inani elikhulu ngenxa yalesi simo se-autoimmune.
Imithi ivunyelwe ngokuqondile kubantu abadala nasebancane abaneminyaka engu-12 nangaphezulu abane-alopecia areata enzima. Lokhu kuhlanganisa abantu abane-alopecia totalis (ukulahlekelwa izinwele ekhanda okuphelele) noma i-alopecia universalis (ukulahlekelwa yizo zonke izinwele zomzimba).
Odokotela ngokuvamile bacabangela i-ritlecitinib uma ezinye izindlela zokwelapha zingasebenzi kahle noma uma ukulahlekelwa izinwele kuningi. Iphinde ifundelwe ezinye izimo ze-autoimmune ezifana ne-vitiligo, nakuba lokhu kusetshenziswa kungakavunywa yi-FDA.
I-Ritlecitinib isebenza ngokuvimba ama-kinases omndeni we-JAK3 kanye ne-TEC, okuyizithunywa ze-molecular ezitshela amasosha akho omzimba ukuthi ahlaselwe. Uma lezi zindlela zisebenza ngokweqile, zithumela amasignali abangela ukuvuvukala nokulimala kwesicubu.
Ngokuphazamisa lezi zimpawu, umuthi usiza ukuthulisa impendulo yamasosha omzimba ezungeze ama-follicles ezinwele. Lokhu kunika izinwele zakho ithuba lokuqala ukukhula futhi ngaphandle kokuphazanyiswa okuqhubekayo kwamasosha omzimba.
Umuthi ubhekwa njengonamandla ngokulinganisela phakathi kwama-inhibitors e-JAK. Ihlosiwe kunezidakamizwa ezithile ezindala ezicindezela amasosha omzimba, okusho ukuthi ingase ibe nemiphumela embalwa ebanzi emzimbeni wakho wamasosha omzimba ngenkathi isasebenza ekukhuleni kabusha kwezinwele.
Kufanele uthathe i-ritlecitinib ngendlela eqondile udokotela wakho ayalela ngayo, ngokuvamile kanye ngosuku ngomlomo. Umuthi ungafakwa nokudla noma ngaphandle kokudla, kodwa ukuwuthatha nokudla kungasiza ukunciphisa noma yikuphi ukuphazamiseka kwesisu.
Gwinya amaphilisi wonke ngenkomishi yamanzi. Ungawachobozi, uwahlafune, noma uwaqhumise, ngoba lokhu kungathinta indlela umuthi ogaywa ngayo emzimbeni wakho.
Zama ukuwuthatha ngesikhathi esifanayo nsuku zonke ukuze ugcine amazinga aqhubekayo ohlelweni lwakho. Uma unenkinga yokukhumbula, ukusetha i-alamu yansuku zonke noma ukuwuthatha nokudla okuvamile kungasiza ukusungula umkhuba.
Akukho imikhawulo ethile yokudla ngenkathi uthatha i-ritlecitinib, kodwa ukugcina ukudla okunempilo, okulinganiselayo kungasekela impilo yakho yonke yamasosha omzimba ngesikhathi sokwelashwa.
Ubude besikhathi sokwelashwa nge-ritlecitinib buyehlukahluka ngokuya ngempendulo yakho kanye nobukhulu besimo sakho. Abantu abaningi badinga ukuyithatha izinyanga eziningana ukuze babone ukukhula kabusha kwezinwele okukhulu.
Udkt wakho cishe uzofuna ukukubona njalo ezinyangeni ezimbalwa ukuze aqaphe inqubekela phambili yakho futhi ahlole noma yimaphi imiphumela emibi. Abanye abantu bangase baqale ukubona ngcono phakathi kwamasonto angu-12, kanti abanye bangase badinge izinyanga eziyisi-6 noma ngaphezulu ukuze babone imiphumela ebalulekile.
Ukwelashwa kuvame ukuba isikhathi eside ngoba i-alopecia areata ingabuyela uma umuthi uyekwa ngaphambi kwesikhathi. Udkt wakho uzosebenza nawe ukuthola ukulinganisela okulungile phakathi kokusebenza kahle nokunciphisa izingozi ezingaba khona ekusetshenzisweni okwandisiwe.
Njengayo yonke imithi, i-ritlecitinib ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Ukuqonda ukuthi yini okufanele uyibheke kungakusiza ukuthi uzizwe ulungiselelwe kangcono futhi wazi ukuthi ungaxhumana nini nomhlinzeki wakho wezempilo.
Imiphumela emibi evamile abantu abaningi abayitholayo ihlanganisa ikhanda, isifo sohudo, nezimpawu ezizwa sengathi umkhuhlane noma umkhuhlane. Lokhu kuvame ukuba mnene futhi kuvame ukuthuthuka njengoba umzimba wakho uzivumela emuthini emasontweni ambalwa okuqala.
Nansi imiphumela emibi ebikwa kaningi:
Imiphumela emibi engathi sína kodwa engavamile idinga ukunakekelwa kwezokwelapha ngokushesha. Lokhu kufaka phakathi izimpawu zokutheleleka okungathi sína, ukuphuma kwegazi okungavamile noma ukulimala, noma umkhuhlane oqhubekayo ongawuphenduli ukwelashwa okuvamile.
Ngenxa yokuthi i-ritlecitinib ithinta amasosha akho omzimba, ungase ube sengozini enkulu yokutheleleka. Qaphela izimpawu ezinjengokukhwehlela okuqhubekayo, ukukhathala okungavamile, noma yiziphi izimpawu zokutheleleka ezibonakala zihlala isikhathi eside kunokujwayelekile.
Imiphumela emibi kodwa ebucayi ihlanganisa ukusabela okukhulu komzimba, izinkinga zesibindi, kanye nezinkinga zokujiya kwegazi. Udokotela wakho uzokuhlola njalo ngezivivinyo zegazi ukuze abambe noma yiziphi zalezi zinkinga zisasekuqaleni.
Abantu abathile kufanele bagweme i-ritlecitinib ngenxa yengozi eyengeziwe yezinkinga ezinzima. Udokotela wakho uzobukeza ngokucophelela umlando wakho wezokwelapha ngaphambi kokukuyalela lo muthi.
Akufanele usebenzise i-ritlecitinib uma unezifo ezinzima ezisebenzayo, okuhlanganisa izifo zamagciwane, amagciwane, noma ezingaveli emvelweni ezingelashwanga. Umuthi ungenza kube nzima ngomzimba wakho ukulwa nezifo.
Abantu abanezimo ezithile zezokwelapha badinga ukucatshangelwa okukhethekile ngaphambi kokuqala ukwelashwa:
Abesifazane abakhulelwe nalabo abahlela ukukhulelwa kufanele baxoxe ngobungozi nezinzuzo ngokucophelela nodokotela wabo. Umuthi kungenzeka awuphephile ngesikhathi sokukhulelwa, futhi ukulawulwa kokuzala okuphumelelayo kuvame ukunconywa ngesikhathi sokwelashwa.
Uma uncelisa, uzodinga ukunquma nodokotela wakho ukuthi uzoqhubeka yini nokuncelisa noma usebenzise umuthi, njengoba ungadlulela obisini lwebele.
I-Ritlecitinib ithengiswa ngaphansi kwegama lomkhiqizo elithi Litfulo e-United States. Leli igama lezentengiso ozolibona emabhodleleni kadokotela kanye nokupakishwa okuvela ekhemisi.
Umuthi ukhiqizwa yi-Pfizer futhi utholakala kuphela ngomyalo odokotela wakho. Izinhlobo ezivamile azitholakali okwamanje njengoba umuthi usamusha emakethe.
Lapho ukhuluma ngomuthi nethimba lakho lezempilo noma usokhemisi, ungaqondisa kuyo nganoma yiliphi igama - i-ritlecitinib noma i-Litfulo - futhi bazokwazi ukuthi usho ukuthini.
Ezinye izindlela zokwelapha zikhona ze-alopecia areata uma i-ritlecitinib ingakulungele noma ingasebenzi kahle. Udokotela wakho angakusiza ukuthi uhlole lezi ezinye izindlela ngokusekelwe esimweni sakho esithile.
Ezinye izinto ezivimbela i-JAK ezifana ne-baricitinib (Olumiant) zisebenza ngendlela efanayo ne-ritlecitinib futhi zingase zibe izinketho kwabanye abantu. Le mithi ivimba izindlela ezihlukile kancane kodwa inezinhloso ezifanayo zokuthulisa ukusebenza ngokweqile kwamasosha omzimba.
Ukwelashwa kwendabuko okuthi odokotela bavame ukukuzama kuqala kufaka phakathi:
Ukwelashwa okusha okucwaningwayo kufaka phakathi ezinye izinto ezivimbela i-JAK kanye ne-biologics eziqondise izindlela ezithile zokuzivikela emzimbeni. Udokotela wakho wesikhumba angaxoxa ngezinketho ezingase zisebenze kangcono ohlotsheni lwakho oluthile nobukhulu bokulahlekelwa izinwele.
Kokubili i-ritlecitinib ne-baricitinib yizinto ezivimbela i-JAK ezingasiza nge-alopecia areata, kodwa zisebenza ngendlela ehlukile kancane futhi zingase zifaneleke kangcono kubantu abahlukene. Akukho noyedwa othi “ungcono” kunomunye.
I-Ritlecitinib ikhetha kakhulu, ikakhulukazi iqondise ama-kinases e-JAK3 ne-TEC, kuyilapho i-baricitinib ivimba izindlela ze-JAK1 ne-JAK2. Lo mahluko ekukhetheni ungase usho ukuthi i-ritlecitinib inemiphumela embalwa kwezinye izinhlelo zomzimba.
Ezivivinyweni zemitholampilo, kokubili imithi yakhombisa ukusebenza kahle okufanayo ekukhuleni kabusha kwezinwele, nabantu abaningi bebona ukuthuthuka okukhulu ngemva kwezinyanga ezimbalwa zokwelashwa. Ukukhetha phakathi kwabo kuvame ukuncika emlandweni wakho wezokwelapha ngamunye kanye nezici eziyingozi.
Udktela wakho uzocabangela izinto ezifana nezinye izimo zakho zempilo, imithi yamanje, kanye nezinto eziyingozi kuwe siqu lapho enquma ukuthi yisiphi isithiyo se-JAK esingasebenza kangcono kuwe. Abanye abantu bangase basabele kangcono emuthini owodwa kunomunye.
Abantu abanesifo sikashukela bangavame ukuthatha i-ritlecitinib, kodwa badinga ukuqashwa eduze ngoba umuthi ungathinta amazinga kashukela egazini. Udokotela wakho uzofuna ukulandela ukuphathwa kwesifo sakho sikashukela ngokucophelela ngesikhathi sokwelashwa.
Umuthi ungase wenze kube nzima kancane ukulwa nezifo, okubaluleke kakhulu kubantu abanesifo sikashukela asebevele benobungozi obukhulu bokutheleleka. Ukuhlolwa njalo kanye nokulawulwa okuhle kukashukela egazini kuba kubaluleke nakakhulu.
Uma ngengozi uthatha i-ritlecitinib eningi kakhulu kunaleyo ebekiwe, xhumana nodokotela wakho noma isikhungo sokulawula ubuthi ngokushesha. Ungalindi ukubona ukuthi ngabe izimpawu ziyavela yini, njengoba ukungenelela kwasekuqaleni kuhlala kungcono.
Ukuthatha okuningi kungakhuphula ingozi yakho yemiphumela emibi engathí sina, ikakhulukazi ehlobene nokucindezelwa kwamasosha omzimba. Umhlinzeki wakho wezempilo angase afune ukukuqapha eduze noma alungise uhlelo lwakho lokwelashwa.
Uma uphuthelwa umthamo we-ritlecitinib, yithathe ngokushesha lapho ukhumbula ngalo lolo suku. Uma sekuyisikhathi esicishe sibe sesikhathini somthamo wakho olandelayo, weqa umthamo ophuthelwe bese uqhubeka neshejuli yakho ejwayelekile.
Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo ophuthelwe, ngoba lokhu kungakhuphula ingozi yakho yemiphumela emibi. Uma uvame ukukhohlwa imithamo, cabanga ukusebenzisa umhleli wamaphilisi noma ukusetha izikhumbuzi zansuku zonke.
Kufanele uyeke kuphela ukuthatha i-ritlecitinib uma udokotela wakho ekutshela ukuthi kuphephile ukwenza kanjalo. Ukuyeka kungazelelwe noma ngaphambi kwesikhathi kungase kubangele ukuthi ukulahlekelwa izinwele kwakho kubuye, njengoba inqubo ye-autoimmune engaphansi ingase iphinde isebenze.
Udokotela wakho uzoqapha intuthuko yakho futhi angase anciphise kancane kancane umthamo wakho noma axoxe ngokuyeka uma usufeze ukukhula kabusha kwezinwele okuzinzile. Isikhathi sihluka kakhulu kumuntu nomuntu ngokuya ngempendulo yomuntu ngamunye nezici eziyingozi.
Ungathola imigomo eminingi ngenkathi uthatha i-ritlecitinib, kodwa kufanele ugweme imigomo ephilayo ngoba ingase ibangele izifo lapho amasosha akho omzimba ecindezelwe. Hlala utshela umhlinzeki wakho wezempilo ngayo yonke imithi oyithathayo ngaphambi kokuthola noma yimuphi umgomo.
Udokotela wakho angase ancome ukuthola imigomo ebalulekile ngaphambi kokuqala ukwelashwa nge-ritlecitinib. Lokhu kuqinisekisa ukuthi unokuvikeleka okungcono kakhulu ezifweni ezingavikeleka ngenkathi amasosha akho omzimba elungiswa ngumuthi.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.